Items where authors include "Peckham, D"
Up a levelArticle
Edwards, AJ, Benson, L, Guo, Z et al. (4 more authors) (2023) A mathematical model for assessing transient airborne infection risks in a multi-zone hospital ward. Building and Environment, 238. 110344. ISSN 0360-1323
Peckham, D orcid.org/0000-0001-7723-1868 and Spoletini, G (2023) Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis. Seminars in Respiratory and Critical Care Medicine, 44 (02). pp. 217-224. ISSN 1069-3424
Reilly, C, Sails, J, Stavropoulos-Kalinoglou, A et al. (6 more authors) (2023) Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis. European Respiratory Review, 32 (167). 220109. ISSN 0905-9180
Elborn, JS, Blasi, F, Burgel, P-R et al. (1 more author) (2023) Role of inhaled antibiotics in the era of highly effective CFTR modulators. European Respiratory Review, 32 (167). 220154. ISSN 0905-9180
Lawless, D, Allen, HL, Thaventhiran, JED et al. (7 more authors) (2023) Prevalence of CFTR variants in PID patients with bronchiectasis - an important modifying co-factor. Journal of Allergy and Clinical Immunology, 152 (1). pp. 257-265. ISSN 0091-6749
Ariza, A, Jaruthamsophon, K, Meng, X et al. (9 more authors) (2022) Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients. Chemical Research in Toxicology, 35 (11). pp. 2122-2132. ISSN 0893-228X
Wilschanski, M and Peckham, D orcid.org/0000-0001-7723-1868 (2022) Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era. Current Opinion in Pulmonary Medicine, 28 (6). pp. 577-583. ISSN 1070-5287
Birch, RJ orcid.org/0000-0003-1579-1397, Peckham, D orcid.org/0000-0001-7723-1868, Wood, HM orcid.org/0000-0003-3009-5904 et al. (7 more authors) (2022) The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: An English population-based study. Journal of Cystic Fibrosis. ISSN 1569-1993
Prokopidis, K, Giannos, P, Witard, OC et al. (2 more authors) (2022) Aberrant mitochondrial homeostasis at the crossroad of musculoskeletal ageing and non-small cell lung cancer. PLoS One, 17 (9). e0273766. ISSN 1932-6203
Caley, L orcid.org/0000-0001-8957-1018 and Peckham, D orcid.org/0000-0001-7723-1868 (2022) Time to change course and tackle CF related obesity. Journal of Cystic Fibrosis, 21 (5). pp. 732-734. ISSN 1569-1993
Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600
Raidt, J, Maitre, B, Pennekamp, P et al. (48 more authors) (2022) The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN. ERJ Open Research, 8 (3). 00139-2022. ISSN 2312-0541
Mainz, JG, Zagoya, C, Polte, L et al. (12 more authors) (2022) Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score. Frontiers in Pharmacology, 13. 877118. ISSN 1663-9812
Chadwick, HK orcid.org/0000-0002-8022-5490, Abbott, J, Hurley, MA et al. (4 more authors) (2022) Cystic fibrosis-related diabetes (CFRD) and cognitive function in adults with cystic fibrosis. Journal of Cystic Fibrosis, 21 (3). pp. 519-528. ISSN 1569-1993
Abbott, J, Hurley, MA, Chadwick, H orcid.org/0000-0002-8022-5490 et al. (1 more author) (2022) Ways of coping and survival in Cystic Fibrosis: a 20-year longitudinal study. Journal of Cystic Fibrosis, 22 (1). pp. 112-118. ISSN 1569-1993
Reilly, C, Stavropoulos Kalinoglou, A, Clifton, I et al. (3 more authors) (2022) Smartphone Pedometers in Adults With Asthma: A Practical Approach to Physical Activity Assessment? A Pilot Validation Study. Journal of Asthma, 59 (5). pp. 967-975. ISSN 0021-9134
Cheah, R, Chirnaksorn, S, Abdelrahim, AH et al. (10 more authors) (2021) The Perils and Pitfalls of Esophageal Dysmotility in Idiopathic Pulmonary Fibrosis. American Journal of Gastroenterology, 116 (6). pp. 1189-1200. ISSN 0002-9270
Lee, DDH, Cardinale, D, Nigro, E et al. (18 more authors) (2021) Higher throughput drug screening for rare respiratory diseases: Readthrough therapy in primary ciliary dyskinesia. European Respiratory Journal, 57 (6). p. 2000455. ISSN 0903-1936
Holbrook, JA, Jarosz-Griffiths, HH, Caseley, E et al. (5 more authors) (2021) Neurodegenerative Disease and the NLRP3 Inflammasome. Frontiers in Pharmacology, 12. 643254. ISSN 1663-9812
Devereux, G, Wrolstad, D, Bourke, SJ et al. (16 more authors) (2020) Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial. PLoS ONE, 15 (12). e0242945. ISSN 1932-6203
Lara-Reyna, S, Holbrook, J orcid.org/0000-0001-8660-0282, Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815 et al. (2 more authors) (2020) Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations. Cellular and Molecular Life Sciences, 77 (22). pp. 4485-4503. ISSN 1420-682X
McClenaghan, E, Cosgriff, R, Brownlee, K et al. (132 more authors) (2020) The global impact of SARS-CoV-2 in 181 people with cystic fibrosis. Journal of Cystic Fibrosis, 19 (6). pp. 868-871. ISSN 1569-1993
Peckham, D orcid.org/0000-0001-7723-1868, McDermott, MF orcid.org/0000-0002-1015-0745, Savic, S orcid.org/0000-0001-7910-0554 et al. (1 more author) (2020) COVID-19 meets Cystic Fibrosis: for better or worse? Genes & Immunity, 21 (4). pp. 260-262. ISSN 1466-4879
Robson, EA, Dixon, L, Causon, L et al. (12 more authors) (2020) Hydrocephalus and diffuse choroid plexus hyperplasia in primary ciliary dyskinesia-related MCIDAS mutation. Neurology Genetics, 6 (4). e482. ISSN 2376-7839
Lipman, M, Cleverley, J, Fardon, T et al. (5 more authors) (2020) Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK. BMJ Open Respiratory Research, 7 (1). e000591. ISSN 2052-4439
Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815, Scambler, T, Wong, CH orcid.org/0000-0003-2108-1615 et al. (11 more authors) (2020) Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis. eLife, 9. e54556. ISSN 2050-084X
Castellani, C, Linnane, B, Pranke, I et al. (3 more authors) (2019) Cystic Fibrosis Diagnosis in Newborns, Children, and Adults. Seminars in Respiratory and Critical Care Medicine, 40 (06). pp. 701-714. ISSN 1069-3424
Scambler, T orcid.org/0000-0003-2468-0218, Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815, Lara-Reyna, S et al. (7 more authors) (2019) ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in Cystic Fibrosis. eLife, 8. e49248. ISSN 2050-084X
Scambler, T, Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815, Lara-Reyna, S et al. (7 more authors) (2019) Excessive ENaC-mediated sodium influx drives NLRP3 inflammasome-dependent autoinflammation in cystic fibrosis. eLife, 8. e49248. ISSN 2050-084X
Lara-Reyna, S, Scambler, T, Holbrook, J et al. (6 more authors) (2019) Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation. Frontiers in Immunology, 10. 1789. ISSN 1664-3224
Smith, L orcid.org/0000-0002-4280-6323, Glaser, AW, Peckham, D orcid.org/0000-0001-7723-1868 et al. (2 more authors) (2019) Respiratory morbidity in young people surviving cancer: Population‐based study of hospital admissions, treatment‐related risk factors and subsequent mortality. International Journal of Cancer, 145 (1). pp. 20-28. ISSN 0020-7136
Alghamdi, NS, Barton, R, Wilcox, M orcid.org/0000-0002-4565-2868 et al. (1 more author) (2019) Serum IgE and IgG reactivity to Aspergillus recombinant antigens in patients with cystic fibrosis. Journal of medical microbiology, 68 (6). ISSN 0022-2615
Tsopra, R, Wyatt, JC, Beirne, P et al. (6 more authors) (2019) Level of accuracy of diagnoses recorded in discharge summaries: A cohort study in three respiratory wards. Journal of Evaluation in Clinical Practice, 25 (1). pp. 36-43. ISSN 1356-1294
Scambler, T, Holbrook, J, Savic, S orcid.org/0000-0001-7910-0554 et al. (2 more authors) (2018) Autoinflammatory disease in the lung. Immunology, 154 (4). pp. 563-573. ISSN 0019-2805
Tsopra, R, Peckham, D orcid.org/0000-0001-7723-1868, Beirne, P et al. (8 more authors) (2018) The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical care. International Journal of Medical Informatics, 115. pp. 35-42. ISSN 1386-5056
Spoletini, G orcid.org/0000-0002-5462-0083, Kennedy, M, Flint, L et al. (7 more authors) (2018) Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre. Pulmonary Pharmacology & Therapeutics, 50. pp. 82-87. ISSN 1094-5539
Lara-Reyna, S, Scambler, T, Holbrook, J et al. (3 more authors) (2018) Regulation of the Unfolded Protein Response in Disease: Cellular Stress and microRNAs. Current Immunology Reviews, 14 (1). pp. 3-14. ISSN 1573-3955
Meng, X, Al-Attar, Z, Yaseen, FS et al. (7 more authors) (2018) Correction: Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients. The Journal of Immunology, 200 (5). p. 1952. ISSN 0022-1767
Sawant, A, Spoletini, G, Whitaker, P et al. (3 more authors) (2018) Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis. ERJ Open Research, 4 (1). 00111-2017. ISSN 2312-0541
Sullivan, A, Wang, E, Farrell, J et al. (5 more authors) (2018) β-lactam hypersensitivity involves expansion of circulating and skin-resident Th22 cells. Journal of Allergy and Clinical Immunology, 141 (1). pp. 235-249. ISSN 0091-6749
Amali, MO, Jenkins, RE, Meng, X et al. (5 more authors) (2017) Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts. Chemical Research in Toxicology, 30 (12). pp. 2097-2099. ISSN 0893-228X
Barr, HL, Halliday, N, Barrett, DA et al. (13 more authors) (2017) Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments. Journal of Cystic Fibrosis, 16 (6). e21. ISSN 1569-1993
Robson, EA, Chetcuti, P, Hirst, RA et al. (6 more authors) (2017) Update on primary ciliary dyskinesia. Paediatrics and Child Health, 27 (7). pp. 337-342. ISSN 1751-7222
Meng, X, Al-Attar, Z, Yaseen, FS et al. (7 more authors) (2017) Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients. Journal of Immunology, 198 (11). pp. 4217-4227. ISSN 0022-1767
Amali, MO, Sullivan, A, Jenkins, RE et al. (7 more authors) (2017) Detection of drug-responsive B-lymphocytes and anti-drug IgG in patients with β-lactam hypersensitivity. Allergy, 72 (6). pp. 896-907. ISSN 0105-4538
Barr, HL, Halliday, N, Barrett, DA et al. (13 more authors) (2017) Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study. Journal of Cystic Fibrosis, 16 (2). pp. 230-238. ISSN 1569-1993
Peckham, D orcid.org/0000-0001-7723-1868, Scambler, T, Savic, S orcid.org/0000-0001-7910-0554 et al. (1 more author) (2017) The burgeoning field of innate immune-mediated disease and autoinflammation. Journal of Pathology, 241 (2). pp. 123-139. ISSN 0022-3417
Chadwick, HK orcid.org/0000-0002-8022-5490, Morton, A, Dye, L et al. (3 more authors) (2016) P98 An 18 (± 6) month follow up study of cognitive function in adults with Cystic Fibrosis Related Diabetes (CFRD). Thorax, 71 (Suppl 3). A136.1-A136. ISSN 0040-6376
Bryant, JM, Grogono, DM, Rodriguez-Rincon, D et al. (78 more authors) (2016) Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science, 354 (6313). pp. 751-757. ISSN 0036-8075
Peckham, D orcid.org/0000-0001-7723-1868 (2016) Electronic patient records, past, present and future. Paediatric Respiratory Reviews, 20 (Supplement). pp. 8-11. ISSN 1526-0542
Fitch, G, Williams, K, Freeston, JE et al. (6 more authors) (2016) Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy. Journal of Cystic Fibrosis, 15 (4). e35-e40. ISSN 1569-1993
Peckham, D, Williams, K, Wynne, S et al. (3 more authors) (2016) Fungal contamination of nebuliser devices used by people with cystic fibrosis. Journal of Cystic Fibrosis, 15 (1). pp. 74-77. ISSN 1569-1993
Wright, KF, Bryant, LD, Morley, S et al. (3 more authors) (2015) Presenting life with cystic fibrosis: a Q-methodological approach to developing balanced, experience-based prenatal screening information. Health Expectations, 18 (5). pp. 1349-1362. ISSN 1369-6513
Peckham, D, Whitaker, P and White, H (2015) Research in progress-electronic patient records: a new era. Thorax, 70 (5). 473 - 475. ISSN 1468-3296
Peckham, D, Etherington, C, White, H et al. (9 more authors) (2014) The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit. Journal of Cystic Fibrosis, 13 (6). pp. 681-686. ISSN 1569-1993
Conway, S, Balfour-Lynn, IM, De Rijcke, K et al. (15 more authors) (2014) European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre. Journal of Cystic Fibrosis, 13 (Suppl 1). S3-S22. ISSN 1569-1993
Gibson, A, Ogese, M, Sullivan, A et al. (7 more authors) (2014) Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function. Journal of Immunology, 192 (6). pp. 2611-2621. ISSN 0022-1767
Peckham, D orcid.org/0000-0001-7723-1868 and Whitaker, P (2013) Drug induced complications; can we do more? Journal of Cystic Fibrosis, 12 (6). pp. 547-558. ISSN 1873-5010
Eaden,, J and Peckham, D orcid.org/0000-0001-7723-1868 (2013) Myocardial infarction in an adult with cystic fibrosis and heart and lung transplant. Multidisciplinary Respiratory Medicine, 8 (1). 37. 37 - ?. ISSN 2049-6958
Reynolds, L, Latchford, G, Duff, AJA et al. (3 more authors) (2013) Decision Making about Risk of Infection by Young Adults with CF. Pulmonary Medicine, 2013. 658638. ISSN 2090-1836
Barton, RC, Borman, AM, Johnson, EM et al. (7 more authors) (2010) Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis. Journal of Clinical Microbiology, 48 (7). pp. 2615-2617. ISSN 1098-660X
Weerasinghe, C, Jesudason, P and Peckham, D orcid.org/0000-0001-7723-1868 (2009) An unusual cause of subarachnoid haemorrhage in a patient with newly diagnosed neurofibromatosis: a case report. Cases Journal, 2 (1). p. 8399. ISSN 1757-1626
Peckham, D orcid.org/0000-0001-7723-1868, Watson, A, Pollard, K et al. (2 more authors) (2002) Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis. Journal of Cystic Fibrosis, 1 (4). pp. 281-286. ISSN 1569-1993
Deakin, M, Elder, J, Hendrickse, C et al. (12 more authors) (1996) Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis, 17 (4). pp. 881-884. ISSN 0143-3334
Humphreys, H, Peckham, D orcid.org/0000-0001-7723-1868, Patel, P et al. (1 more author) (1994) Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis. Thorax, 49 (11). pp. 1157-1159. ISSN 0040-6376
Conference or Workshop Item
Reilly, C, Clifton, I, Peckham, D et al. (2 more authors) (2022) Impact of COVID-19 restrictions on physical activity in adults with severe asthma: a preliminary two-year retrospective analysis. In: ERS International Congress 2022 abstracts, 04-06 Sep 2022, Barcelona, Spain.
Reilly, C, Sails, J, Birch, R et al. (5 more authors) (2022) Physical activity promotion interventions in chronic airways disease: preliminary findings from a scoping review and meta-analysis. In: ERS International Congress 2022 abstracts, 04-06 Sep 2022, Barcelona, Spain.
Haigh, L, Chadwick, HK, Gillgrass, L et al. (10 more authors) (2021) P206 Patient feedback following the introduction of a dedicated ‘Symkevi® Initiation Clinic’ prior to starting modulator therapy. In: 44th European Cystic Fibrosis Conference.
Milligan, CM, Pollard, K, Watson, R et al. (4 more authors) (2021) P86 Physiotherapist-led online exercise session for people with cystic fibrosis (CF) during the COVID-19 pandemic: a service evaluation. In: British Thoracic Society Winter Meeting, 08-12 Feb 2021, Online.
Spoletini, G, Watson, R, Pollard, K et al. (4 more authors) (2020) Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial. In: 2020 ERS International Congress, 06-09 Sep 2020, Online.
Wheway, G, Legebeke, J, Carr, SB et al. (21 more authors) (2020) Primary ciliary dyskinesia and non-CF bronchiectasis in the 100,000 Genomes Project. In: 2020 ERS International Congress, 06-09 Sep 2020, Online.
Lim, Y, Etherington, C, Spoletini, G et al. (2 more authors) (2020) Cancer risk in cystic fibrosis patients: a 13-year experience in a UK regional centre. In: 43rd European Cystic Fibrosis Conference, 24-25 Sep 2020, Online.
Jarosz-Griffiths, H, Scambler, T, Wong, C et al. (11 more authors) (2020) WS12.6 Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis. In: 43rd European Cystic Fibrosis Conference, 24-25 Sep 2020, Online.
Shimmin, D, Mansfileld, M, Lim, Y et al. (3 more authors) (2020) WS15.4 Early experience of flash glucose monitoring using the Freestyle Libre System in adults with Cystic Fibrosis-Related Diabetes (CFRD) attending a large regional UK centre. In: 43rd European Cystic Fibrosis Conference, 24-25 Sep 2020, Online.
Caley, L, Smith, L, White, H et al. (1 more author) (2020) WS23.3 The average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: data from the UK Cystic Fibrosis Registry. In: 43rd European Cystic Fibrosis Conference, 24-25 Sep 2020, Online.
Shires, M, Marks, K, Peckham, D orcid.org/0000-0001-7723-1868 et al. (1 more author) (2020) SA1092 Apical BK Channels in Intestinal Epithelia of Cystic Fibrosis (CF) Patients: a Potential Target for Stimulating Potassium Driven Water Secretion. In: Digestive Disease Week, 02-05 May 2020, Online.
Spoletini, G, Pollard, K, Watson, R et al. (4 more authors) (2019) Outcomes at 6 months following NIV in adults with cystic fibrosis (CF): experience of a large UK centre. In: ERS International Congress 2019, 28 Sep - 02 Oct 2019, Madrid, Spain.
Spoletini, G, Watson, R, Pollard, K et al. (4 more authors) (2019) Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre. In: ERS International Congress 2019, 28 Sep - 02 Oct 2019, Madrid, Spain.
Fajac, I, Peckham, D orcid.org/0000-0001-7723-1868, Wheeler, A et al. (1 more author) Double-Blind, Placebo-Controlled, Randomized Study of SPX-101, a Novel Modulator of ENaC Cell Surface Density in Adults With Cystic Fibrosis. In: 41st European Cystic Fibrosis Conference, 06-09 Jun 2018, Belgrade.
Scambler, T, Wong, CHI, Savic, S orcid.org/0000-0001-7910-0554 et al. (2 more authors) Inflammasome activation in cystic fibrosis bronchial epithelial cells is exacerbated in hypoxia. In: The 40th European Cystic Fibrosis Society Conference, 07-10 Jun 2017, Seville, Spain.
Proceedings Paper
Smith, C, Chadwick, H orcid.org/0000-0002-8022-5490, Farinha, C et al. (22 more authors) (2023) P136 ECFS syllabuses for the multidisciplinary team and wider field: a guide for comprehensive education. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier , S106-s106.
Gillgrass, L, Haigh, L, Pollard, K et al. (6 more authors) (2023) P366 Developing an in-house and integrated sweat testing service for the routine management of adults with cystic fibrosis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier , S176-S176.
Caley, L orcid.org/0000-0001-8957-1018, White, H, Jaudszus, A et al. (2 more authors) (2020) ePS2.03 Prevalence of gastrointestinal symptoms in pancreatic insufficient adults with cystic fibrosis: a UK cohort study. In: Journal of Cystic Fibrosis. 43rd European Cystic Fibrosis Conference, 2020, 24-25 Sep 2020, Online. Elsevier , S40-S40.
Caley, L orcid.org/0000-0001-8957-1018, Smith, L, White, H et al. (1 more author) (2020) The Average Rate of Lung Function Decline in Adults with Cystic Fibrosis in the United Kingdom: Data from the UK CF Registry. In: To be confirmed. European Cystic Fibrosis Conference, 03-06 Jun 2020. . (In Press)
Chadwick, HK, Sawant, AP, White, H et al. (4 more authors) (2019) Evaluation of providing patient online access to electronic health care records (EHR) in cystic fibrosis. In: Pediatric Pulmonology. The 33rd Annual North American Cystic Fibrosis Conference, 31 Oct - 02 Nov 2019, Nashville, Tennessee, USA. Wiley , p. 399.
White, H, Shaw, N, Gillgrass, L et al. (3 more authors) (2019) Randomized controlled trial of a web-based intervention for adherence in cystic fibrosis. In: Pediatric Pulmonology. The 33rd Annual North American Cystic Fibrosis Conference, 31 Oct - 02 Nov 2019, Nashville, Tennessee, USA. John Wiley & Sons Inc. , S420-S420.
Shimmin, D, White, H, Etherington, C et al. (1 more author) (2019) Impact of continuous subcutaneous insulin infusion (CSII) pump use for Cystic Fibrosis-Related Diabetes (CFRD). In: Journal of Cystic Fibrosis. 42nd European Cystic Fibrosis Conference, 05-08 Jun 2019, Liverpool, United Kingdom. Elsevier BV , S141.
Jarosz-Griffiths, H orcid.org/0000-0001-5154-4815, Scambler, T, Lara Reyna, S orcid.org/0000-0002-9986-5279 et al. (7 more authors) (2019) ePS1.09 Inhibition of autoinflammation in cystic fibrosis using small molecule therapy. In: Journal of Cystic Fibrosis. 42nd European Cystic Fibrosis Conference, 05-08 Jun 2019, Liverpool, UK. Elsevier , S41.
Jarosz-Griffiths, H orcid.org/0000-0001-5154-4815, Scambler, T, Holbrook, J et al. (5 more authors) (2018) S138 Inhibition of auto-inflammation in cystic fibrosis using small molecule therapy. In: Thorax. Winter Meeting of the British-Thoracic-Society, 05-07 Dec 2018, Westminster, England. BMJ Publishing Group , A86-A86.
Smith, L, Glaser, AW, Peckham, D et al. (2 more authors) (2018) P34 Risk and impact of respiratory hospitalisation among childhood and young adult cancer survivors. In: Thorax. British Thoracic Society Winter Meeting 2018, 05-07 Dec 2018, London. BMJ Publishing Group , A114-A114.
Chadwick, HK orcid.org/0000-0002-8022-5490, White, H, Shaw, N et al. (5 more authors) (2018) Aztreonam lysine inhalation solution stabilises lung function decline in patients with cystic fibrosis and moderate to severe lung disease. In: Pediatric Pulmonology. NACFC 2018: the 32nd Annual North American Cystic Fibrosis Conference, 18-20 Oct 2018, Denver, CO, USA. Wiley , p. 331.
Devereux, G, Bourke, S, Daines, C et al. (17 more authors) (2018) CARE-CF-1 TRIAL: CYSTEAMINE, AN ORAL ADJUNCT TO STANDARD OF CARE INTERVENTIONS IN CF INFECTIOUS EXACERBATIONS. In: Pediatric Pulmonology. 32nd Annual North American Cystic Fibrosis Conference 2018, 18-20 Oct 2018, Denver, Colorado. Wiley , p. 260.
Scambler, T, Wong, C, Pathak, S et al. (7 more authors) (2018) Enac modulates innate immune inflammation and metabolism in cystic fibrosis. In: Pediatric Pulmonology. 32nd Annual North American Cystic Fibrosis Conference, 18-20 Oct 2018, Denver, CO, USA. Wiley , pp. 184-185.
Lara Reyna, S orcid.org/0000-0002-9986-5279, Scambler, T, Holbrook, J et al. (6 more authors) (2018) Overactivation of IRE1α drives overexpression of IL-6 in cystic fibrosis. In: Pediatric Pulmonology. 32nd Annual North American Cystic Fibrosis Conference, 18-20 Oct 2018, Denver, CO, USA. Wiley , p. 189.
Holbrook, J, Scambler, T, Lara Reyna, S orcid.org/0000-0002-9986-5279 et al. (5 more authors) (2018) The effect of cysteamine and epigallocatechin gallate on the inflammatory phenotype in cystic fibrosis. In: Pediatric Pulmonology. 32nd Annual North American Cystic Fibrosis Conference, 18-20 Oct 2018, Denver, CO, USA. Wiley , p. 245.
Ibrahim, MET, Clarke, E, Martin, K et al. (5 more authors) (2018) Cystic fibrosis and inflammatory arthritis requiring immunosuppression: a worrying combination? In: Annals of the Rheumatic Diseases. EULAR 2018: Annual European Congress of Rheumatology, 13-16 Jun 2018, Amsterdam, Netherlands. BMJ Publishing Group , p. 1679.
Scambler, T orcid.org/0000-0003-2468-0218, Wong, C, Pathak, S et al. (7 more authors) (2018) WS04.3 Sodium influx modulates innate immune inflammation and metabolism in cystic fibrosis. In: Journal of Cystic Fibrosis. 41st European Cystic Fibrosis Conference, 06-09 Jun 2018, Belgrade, Serbia. Elsevier BV , S8-S8.
Clarke, EA, Ibrahim, M, Martin, K et al. (5 more authors) (2018) P130 Immunosuppression in cystic fibrosis: how worried should we be? In: Journal of Cystic Fibrosis 2018;17(3):S95–S96. 41ST European Cystic Fibrosis Society Conference, Belgrade, Serbia, 06-09 Jun 2018. Elsevier , S95-S96.
Alghamdi, N, Peckham, D orcid.org/0000-0001-7723-1868 and Barton, R (2018) Serum IgE and IgG Reactivity to Aspergillus Recombinant Antigens in Patients with Cystic Fibrosis. In: Medical Mycology. 20th Congress of the International Society for Human and Animal Mycology (ISHAM 2018), 30 Jun - 04 Jul 2018, Amsterdam, Netherlands. Oxford University Press , S77-S77.
Clarke, EA, Taylor, J, Horsley, AR et al. (7 more authors) (2018) Musculoskeletal symptoms represent a significant burden for adults with cystic fibrosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, UK. Oxford Academic .
White, H, Shaw, N, Gillgrass, L et al. (3 more authors) (2017) Evaluation of an RCT Web Based Intervention for Adherence in Cystic Fibrosis. In: Pediatric Pulmonology. 31st annual North American Cystic Fibrosis Conference (NACFC), 02-04 Nov 2017, Indianapolis, Indiana, USA. Wiley-Blackwell , S503-S503.
Chadwick, HK, Morton, AM, Dye, L orcid.org/0000-0002-2331-4227 et al. (3 more authors) (2016) Cognitive function in adult post-transplant patients with cystic fibrosis (CF) compared to non-transplant patients with CF and healthy controls. In: Journal of Cystic Fibrosis. 39th European Cystic Fibrosis Conference, 08-11 Jun 2016, Basel, Switzerland. Elsevier , S111-S111.
Fitch, G, Williams, K, Freeston, J et al. (3 more authors) (2015) Defining the cystic fibrosis arthropathy phenotype: A serological and imaging pilot study. In: Journal of Cystic Fibrosis. 38th European Cystic Fibrosis Conference, 10-13 Jun 2015, Brussels. Elsevier , S62-S62.